查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726267

全球停經後骨質疏鬆症治療市場：市場規模、佔有率和趨勢分析（按藥物類別、類型、分銷管道和地區），按細分市場預測（2025-2030 年）

Postmenopausal Osteoporosis Treatment Market Size, Share & Trends Analysis Report By Drug Class (Branded, Generics), By Type (Bisphosphates, Parathyroid Hormone Therapy), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

停經後骨質疏鬆症治療市場的成長與趨勢：

根據 Grand View Research, Inc. 的新報告，全球停經後骨質疏鬆症治療市場預計到 2030 年將達到 137 億美元，2025 年至 2030 年的複合年成長率為 4.6%。

由於老年人口的增加和生活方式的改變，市場正在經歷顯著成長。由於老年人口極易受到影響，預計將成為市場擴張的主要驅動力。例如，根據世界衛生組織 (WHO) 2021 年 10 月的報告，預計 60 歲及以上人口數量將從 2020 年的 10 億增加到 2030 年的 14 億，到 2050 年將達到 21 億。因此，由於老年人對停經後骨質疏鬆症治療的需求不斷增加，預計市場在預測期內將會擴大。

此外，缺乏運動、過度飲酒、吸煙、長時間工作和不健康的飲食習慣等不良的生活習慣會影響更年期，並增加全球許多女性患骨質疏鬆症的風險。此外，年齡、吸菸、飲酒、過量使用促性腺激素分泌和甲狀腺激素以及使用細胞毒性藥物等抗病藥物都是導致停經後婦女骨骼密度下降和症狀的一些風險因素。這將成為市場成長的驅動力。根據國際更年期協會（IMS）的統計，預計2021年將有超過2億女性罹患骨質疏鬆症，50歲以上女性中每3人中就有1人會遭遇骨質疏鬆性骨折。由於上述因素，預計市場在預測期內將會擴大。

然而，預測期內人們預計對該疾病的認知不足將阻礙該行業的發展。在預測期內，由於產業參與者和研究機構的投資，研發力道可能會大幅增加。例如，根據 clinicaltrial.gov 上發布的資訊，截至 2021 年 6 月，美國正在進行大約 25 項骨質疏鬆症藥物的 III 期和 IV 期臨床試驗。例如，禮來公司發展出人源化 IgG4 單株抗體 brosozumab，用於治療停經後骨質疏鬆症。它是SOST蛋白的抑制劑，目前正處於II期臨床試驗階段。

停經後骨質疏鬆症治療市場報告重點

  • 品牌骨質疏鬆症藥物將佔據市場主導地位，到 2024 年將佔 54.0% 的佔有率。這些藥物因其經過驗證的療效、監管部門的核准和強大的市場佔有率而被廣泛使用。
  • 2024年，零售藥局將佔據市場主導地位。老年人口的成長和骨質疏鬆症盛行率的上升是推動透過此通路銷售藥品需求的主要因素。
  • 由於主要市場參與企業的強大影響力、研發支出的增加以及聯邦政府的支持，北美在 2024 年佔據了最大的佔有率。
  • 由於目標疾病盛行率上升、人口老化加劇以及停經後骨質疏鬆症藥物的採用率增加，預計亞太地區在預測期內的複合年成長率最高。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章停經後骨質疏鬆症治療市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTEL分析

第4章停經後骨質疏鬆症治療市場：依藥物類別分類的業務分析

  • 各藥品類別的市場佔有率（2024 年及 2030 年）
  • 藥物類別儀表板
  • 依藥品類別分類的市場規模預測及趨勢分析（2018-2030年）
  • 品牌
  • 學名藥

第5章停經後骨質疏鬆症治療市場：按類型分類的業務分析

  • 按類型分類的市場佔有率（2024 年和 2030 年）
  • 按類型分類的儀表板
  • 按類型分類的市場規模預測和趨勢分析（2018-2030）
  • 雙磷酸鹽
  • 副甲狀腺素治療
  • 抑鈣素
  • 選擇性雌激素抑制劑調變器（SERM）
  • 活化因數配體抑制劑
  • 其他產品

第6章停經後骨質疏鬆症治療市場：通路業務分析

  • 按分銷管道分類的市場佔有率（2024 年和 2030 年）
  • 分銷通路儀表板
  • 按分銷管道分類的市場規模預測和趨勢分析（2018-2030 年）
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第7章停經後骨質疏鬆症治療市場：按地區估計和趨勢分析

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 按國家/地區（2018-2030 年）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區（2018-2030 年）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區（2018-2030 年）
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區（2018-2030 年）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區（2018-2030 年）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 參與者概覽
  • 公司市場地位分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Amgen Inc.
    • Eli Lilly and Company
    • Merck &Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • AbbVie Inc.
    • Cipla
    • Teva Pharmaceutical Industries Ltd.
    • F. Hoffmann-La Roche Ltd
Product Code: GVR-4-68040-065-0

Postmenopausal Osteoporosis Treatment Market Growth & Trends:

The global postmenopausal osteoporosis treatment market size is expected to reach USD 13.7 billion by 2030 and is expected to expand at a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has grown significantly as a result of the growing geriatric population and lifestyle changes. As the older population is more susceptible, their population growth is anticipated to be a major driving force behind the market expansion. For instance, the number of people aged 60 years and above is predicted to rise from 1 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050, according to the World Health Organization's October 2021 report. As a result, the market is anticipated to expand during the forecast period due to a rise in demand for postmenopausal osteoporosis treatment among older people.

In addition, lifestyle modifications like inactivity, excessive alcohol consumption, smoking, long work hours, and unhealthy eating patterns have an impact on menopause and increase the risk of osteoporosis in many women around the globe. Furthermore, age, smoking, alcohol consumption, and the use of drugs to address illnesses like gonadotropins, excessive thyroid hormone use, & cytotoxic agents are a few of the risk factors that can lead to low bone density and the development of the condition in women after menopause. Thus, it will drive the market growth. In 2021, more than 200 million women were affected with osteoporosis, and 1 in 3 women over 50 years of age are predicted to sustain an osteoporosis fracture, according to statistics from the International Menopause Society (IMS). As a result of the aforementioned factors, it is anticipated that the studied market will expand over the projected period.

However, it is anticipated that during the projection era, low awareness about the disease will impede industry growth. In the forecast period, there will likely be a significant increase in research and development efforts as a result of investments made by industry participants and research institutions. For instance, according to the information posted on clinicaltrial.gov, as of June 2021, there were approximately 25 ongoing phase III as well as phase IV clinical trials for osteoporosis medications in the U.S. Consequently, as a result of the aforementioned factors, the market is expected to grow over the forecast period. For instance, Eli Lilly and Company is creating blosozumab, a humanized IgG4 monoclonal antibody, to treat postmenopausal osteoporosis. It is an inhibitor of the SOST protein and is presently undergoing phase II clinical studies.

Postmenopausal Osteoporosis Treatment Market Report Highlights:

  • Branded osteoporosis drugs dominated the market, accounting for a share of 54.0% in 2024. These medications are widely used due to their proven effectiveness, regulatory approvals, and strong market presence.
  • Retail pharmacies dominated the market in 2024. The growing geriatric population and the increasing prevalence of osteoporosis have been key factors driving the demand for medications through this distribution channel.
  • North America held the largest share in 2024 due to the strong presence of key market participants, as well as rising R&D spending and federal assistance, in the region
  • Asia Pacific is expected to grow at the highest CAGR over the projected period due to the rising prevalence of target disease, the growing aging population, and the increasing adoption of postmenopausal osteoporosis treatments

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Type
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Postmenopausal Osteoporosis Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Postmenopausal Osteoporosis Treatment Market: Drug Class Business Analysis

  • 4.1. Drug Class Market Share, 2024 & 2030
  • 4.2. Drug Class Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 4.4. Branded
    • 4.4.1. Branded Market, 2018 - 2030 (USD Million)
  • 4.5. Generics
    • 4.5.1. Generics Market, 2018 - 2030 (USD Million)

Chapter 5. Postmenopausal Osteoporosis Treatment Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Bisphosphonates
    • 5.4.1. Bisphosphonates Market, 2018 - 2030 (USD Million)
  • 5.5. Parathyroid Hormone Therapy
    • 5.5.1. Parathyroid Hormone Therapy Market, 2018 - 2030 (USD Million)
  • 5.6. Calcitonin
    • 5.6.1. Calcitonin Market, 2018 - 2030 (USD Million)
  • 5.7. Selective Estrogen Inhibitors Modulator (SERM)
    • 5.7.1. Selective Estrogen Inhibitors Modulator (SERM) Market, 2018 - 2030 (USD Million)
  • 5.8. Rank Ligand Inhibitors
    • 5.8.1. Rank Ligand Inhibitors Market, 2018 - 2030 (USD Million)
  • 5.9. Other Products
    • 5.9.1. Other Products Market, 2018 - 2030 (USD Million)

Chapter 6. Postmenopausal Osteoporosis Treatment Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 7. Postmenopausal Osteoporosis Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Postmenopausal Osteoporosis Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Amgen Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Eli Lilly and Company
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Merck & Co., Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Novartis AG
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Pfizer Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. AbbVie Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Cipla
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Teva Pharmaceutical Industries Ltd.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. F. Hoffmann-La Roche Ltd
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Postmenopausal Osteoporosis Treatment Market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Global Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 6 Global Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 North America Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 9 North America Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Canada Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Mexico Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 18 Mexico Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Mexico Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Europe Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Europe Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 UK Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 25 UK Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 UK Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 28 Germany Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 France Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 31 France Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 France Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 Italy Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Italy Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Italy Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 Spain Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Spain Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Spain Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Norway Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40 Norway Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 41 Norway Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Denmark Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Denmark Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 45 Sweden Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Sweden Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Japan Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Japan Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 54 Japan Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 China Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 56 China Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 China Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 India Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 59 India Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 India Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61 Australia Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Australia Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65 South Korea Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 Thailand Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 68 Thailand Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 69 Thailand Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Latin America Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 72 Latin America Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 Latin America Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 74 Brazil Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75 Brazil Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Brazil Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 Argentina Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 78 Argentina Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 South Africa Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 85 South Africa Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 90 UAE Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91 UAE Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Postmenopausal Osteoporosis Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Postmenopausal Osteoporosis Treatment Market, by Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Postmenopausal Osteoporosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Postmenopausal Osteoporosis Treatment Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation Drug Class
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug Class, Type and Distribution Channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Postmenopausal Osteoporosis Treatment Market dynamics
  • Fig. 12 Postmenopausal Osteoporosis Treatment Market: Porter's five forces analysis
  • Fig. 13 Postmenopausal Osteoporosis Treatment Market: PESTLE analysis
  • Fig. 14 Postmenopausal Osteoporosis Treatment Market: Drug Class segment dashboard
  • Fig. 15 Postmenopausal Osteoporosis Treatment Market: Drug Class market share analysis, 2024 & 2030
  • Fig. 16 Branded market, 2018 - 2030 (USD Million)
  • Fig. 17 Generics market, 2018 - 2030 (USD Million)
  • Fig. 18 Postmenopausal Osteoporosis Treatment Market: Type segment dashboard
  • Fig. 19 Postmenopausal Osteoporosis Treatment Market: Type market share analysis, 2024 & 2030
  • Fig. 20 Bisphosphonates market, 2018 - 2030 (USD Million)
  • Fig. 21 Parathyroid Hormone Therapy market, 2018 - 2030 (USD Million)
  • Fig. 22 Calcitonin market, 2018 - 2030 (USD Million)
  • Fig. 23 Selective Estrogen Inhibitors Modulator (SERM) market, 2018 - 2030 (USD Million)
  • Fig. 24 Rank Ligand Inhibitors market, 2018 - 2030 (USD Million)
  • Fig. 25 Other Products market, 2018 - 2030 (USD Million)
  • Fig. 26 Postmenopausal Osteoporosis Treatment Market: Distribution Channel segment dashboard
  • Fig. 27 Postmenopausal Osteoporosis Treatment Market: Distribution Channel market share analysis, 2024 & 2030
  • Fig. 28 Hospital Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 29 Retail Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 30 Online Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 31 Postmenopausal Osteoporosis Treatment Market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. country dynamics
  • Fig. 36 U.S. Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada country dynamics
  • Fig. 38 Canada Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico country dynamics
  • Fig. 40 Mexico Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK country dynamics
  • Fig. 43 UK Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany country dynamics
  • Fig. 45 Germany Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 46 France country dynamics
  • Fig. 47 France Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy country dynamics
  • Fig. 49 Italy Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain country dynamics
  • Fig. 51 Spain Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 52 Norway country dynamics
  • Fig. 53 Norway Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden country dynamics
  • Fig. 55 Sweden Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark country dynamics
  • Fig. 57 Denmark Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan country dynamics
  • Fig. 60 Japan Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 61 China country dynamics
  • Fig. 62 China Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 63 India country dynamics
  • Fig. 64 India Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia country dynamics
  • Fig. 66 Australia Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea country dynamics
  • Fig. 68 South Korea Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand country dynamics
  • Fig. 70 Thailand Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil country dynamics
  • Fig. 73 Brazil Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 74 Argentina country dynamics
  • Fig. 75 Argentina Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 76 MEA Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa country dynamics
  • Fig. 78 South Africa Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia country dynamics
  • Fig. 80 Saudi Arabia Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE country dynamics
  • Fig. 82 UAE Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 83 Kuwait country dynamics
  • Fig. 84 Kuwait Postmenopausal Osteoporosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 85 Company categorization
  • Fig. 86 Company market position analysis
  • Fig. 87 Strategic framework